João Ribas

João Ribas is an accomplished professional with extensive experience in the biotech sector. Currently, João serves as Principal at Novo Holdings, where responsibilities include investing in early-stage biotech companies, portfolio management, and strategic initiatives. Additionally, João holds the position of Chief Business Officer and Board Member at Booster Therapeutics and Asgard Therapeutics, respectively, contributing to direct in vivo reprogramming approaches in oncology. Other notable roles include Chief Business Officer and Board Member at Orbis Medicines, Board Member at Tribune Therapeutics, and Board Observer positions at Engimmune Therapeutics, Draupnir Bio, AMRA Medical, and Biosyntia. João co-founded The Future Labs and is pursuing further education with a Board of Directors Diploma at IMD, following advanced studies in bioengineering and biomedical engineering at Harvard Medical School and Universidade de Coimbra.